IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10092658 B1

PDFFull Text
Date of Patent:
Oct. 09, 2018

Filed:

Feb. 07, 2013

Method for manufacturing transdermally delivered hyaluronic acid-protein conjugate and transdermally delivered hyaluronic acid-protein conjugate manufactured using same

Applicant:

Phi Biomed Co., Ltd., Seoul, KR;

Inventors:

Sei Kwang Hahn, Pohang-si, KR;

Eung-Sam Kim, Pohang-si, KR;

Jeonga Yang, Pohang-si, KR;

Hyemin Kim, Pohang-si, KR;

Kwan Yong Choi, Pohang-si, KR;

Ji Hye Shin, Daegu, KR;

Jung-Hee Kwon, Pohang-si, KR;

Assignee:

PHI BIOMED CO., LTD., Seoul, KR;

Attorney:

Lex IP Meister, PLLC

Primary Examiner:

Karlheinz R Skowronek

Assistant Examiner:

Ronald T Niebauer

Int. Cl.
CPC ...
A61K 47/36 (2006.01); A61K 47/48 (2006.01); C07K 17/10 (2006.01); C08B 37/08 (2006.01); C08H 1/00 (2006.01); C08L 5/08 (2006.01); C08L 89/00 (2006.01); A61K 8/64 (2006.01); A61K 8/73 (2006.01); A61K 38/27 (2006.01); A61K 39/00 (2006.01); A61Q 19/00 (2006.01); C07K 14/61 (2006.01); A61K 47/61 (2017.01);
U.S. Cl.
CPC ...
A61K 47/4823 (2013.01); A61K 8/64 (2013.01); A61K 8/735 (2013.01); A61K 38/27 (2013.01); A61K 39/00 (2013.01); A61K 47/61 (2017.08); A61Q 19/00 (2013.01); C07K 14/61 (2013.01); C07K 17/10 (2013.01); C08B 37/0072 (2013.01); C08H 1/00 (2013.01); C08L 5/08 (2013.01); C08L 89/00 (2013.01); A61K 2039/6087 (2013.01); A61K 2800/57 (2013.01); A61K 2800/91 (2013.01);
Abstract

A transdermal delivery system of drug and a method of preparing the same are provided. More specifically, the invention can be a transdermal delivery system applied for various protein drugs such as vaccines and chemical drugs, because the drug delivery system has a biocompatibility, biodegradation property, transdermal delivery property, the safety of human body, maximum activity of protein drugs, good bio-conjugation efficiency and a long-term efficacy, a method of preparing the same and its use.

Find Patent Forward Citations

Loading…